About us

Volta Medical is a data-inspired, AI solutions electrophysiology company, whose mission is to aid in the treatment of complex heart rhythm disease.

Founded in 2016 by a data scientist and 3 electrophysiologists.

Strong AI product pipeline; proven data collection, curation & labeling capabilities.

Proven track-record in running large scale international clinical trials.

Total capital raised over €90M.

Our Investors & Partners

Key events timeline
2016
Volta Medical is founded by a data scientist, Théophile Mohr Durdez and three electrophysiologists: Dr. Julien Seitz, Dr. Jérôme Kalifa and Dr. Clément Bars.
NOVEMBER
Seed Series €2.6M - Lead Investor Groupe Pasteur Mutualité
2018
JULY
First patient included in the Ev-AIFib Study
2019
APRIL
Deep Tech Award
2020
JANUARY
VX1 CE Marked
SEPTEMBER
VX1 FDA Cleared
OCTOBER
First Commercial Case
NOVEMBER
Series A €23M - Lead Investor Gilde Healthcare
2021
FEBRUARY
First patient included in the Tailored AF-Study
2022
SEPTEMBER
Publication of the EV-AIFib Study
2023
JANUARY
Series B €36M - Lead Investor Vensana Capital

Volta AF-Xplorer™ FDA Cleared
JUNE
Initiation of the RESTART Clinical Trial
OCTOBER
Best Startup Prix Galien Award
2024
FEBRUARY
Volta AF-Xplorer™ CE Marked
MAY
Presentation of Tailored-AF results
The future is bright. Check back for our future milestones !